Media
Contact:
Lisa M. Becker
Cold Spring Harbor Laboratory
516-367-8489
becker@cshl.edu
|
|
|
| |
|
|
June 10, 2004
|
|
Cold Spring
Harbor Scientist Bruce Stillman Awarded
Alfred P. Sloan,
Jr. Prize
Shares $250,000 General Motors Award For
Outstanding Basic
Science Contributions to Cancer Research
|
DETROIT – Bruce Stillman, president and CEO,
Cold Spring Harbor Laboratory in Cold Spring Harbor, N.Y., has
been awarded the Alfred P. Sloan, Jr. Prize, one of three awards
given annually by the General Motors Cancer Research Foundation
(GMCRF). The Sloan Prize recognizes the most outstanding recent
contribution in basic science related to cancer research. Along
with the Kettering Prize and Mott Prize, also awarded by the
GMCRF, this high honor has been bestowed on a select number of
the world’s top scientists, 12 of whom have subsequently
won Nobel Prizes.
Stillman, along with co-winner Dr. Thomas Kelly, director, Sloan-Kettering
Institute of New York, was cited for his major contributions
to our understanding of the biochemistry and regulation of DNA
replication in cells with a nucleus (eukaryotes), which include
human cells.
“Understanding the process of DNA replication in normal
cells has been important for us to understand what goes wrong
in cancer
cells,” Stillman said. “We’ve learned so much
about the process of chromosome duplication and how it integrates
into the biochemical pathways that are defective in cancer cells.”
Stillman’s work has had a profound impact in the field
of cancer research. Studying DNA replication in both human cells
and yeast extracts, Stillman made two significant discoveries.
In the 1980s, Dr. Kelly and he discovered the protein machinery
that enables chromosomes to be copied. In 1992, he discovered
a protein complex (the Origin of Recognition Complex, or ORC)
that regulates the copying process.
The significance of his discoveries to cancer, according to Stillman,
is that entire chromosomes need to be copied accurately and just
once in the cell division process.
“If parts of chromosomes are copied more than once before
cell division, cells can acquire abnormalities in the number
of genes,” Stillman
said. “A characteristic of cancer cells is that they have
an altered number of genes compared to normal cells. Furthermore,
some cancer cells do not copy DNA accurately, which results in
mutations.”
When Stillman completed his doctorate work, he sought a postdoctoral
position with Cold Spring Harbor Laboratory, led at the time
by Jim Watson, who along with Francis Crick discovered the double
helix structure of DNA.
“I was excited about Cold Spring Harbor because Jim had
set up a lab specifically to work on the cancer-causing DNA viruses
that I had been studying,” Stillman said. “The resources
were extraordinary, and it was like coming to a playground that
had lots of great toys and many amazing scientists.”
“I was surprised and obviously very pleased when I learned
I won the Sloan Prize with Tom Kelly,” Stillman added. “I
believe the award is a recognition for the accomplishments of
the entire field of chromosome replication. It’s not only
Tom Kelly’s and my work, but the combined efforts of all
my students and postdoctoral fellows and others in the field
who have made outstanding contributions.”
A native of Sydney, Australia, Stillman earned his bachelor’s
degree from the University of Sydney and his doctorate from the
John Curtain School of Medical Research at the Australian National
University. He is a member of the National Academy of Sciences,
Order of Australia and a Fellow of the Royal Society (London).
Dr. Samuel A. Wells, Jr., president of the GMCRF, called Stillman
an exemplary scientist and a worthy recipient of the Sloan Prize. “Bruce
was chosen through a rigorous process conducted by a panel of
prestigious international scientists,” he said.
GM has made cancer research a key philanthropic priority, and
this year marks the 26th anniversary of the GMCRF Awards. GM
has given more than $50 million to the cause, and is committed
to helping eradicate cancer by supporting cancer research until
the battle is won.
“Cancer research is crucial, because the effects of the
disease are so far-reaching,” said GMCRF Chairman Harry
J. Pearce. Pearce, a cancer survivor, has indicated on many occasions
that
he credits cancer research with saving his life. “Over
10,600 GM employees, retirees and their family members were treated
for cancer in the past year alone.”
As part of the commitment to cancer research, the automaker established
the GMCRF in 1978 to recognize the outstanding accomplishments
of basic scientists and clinical scientists in cancer research
around the world.
The Sloan Prize, among the most prestigious in the field of medicine,
is one of three awards GM announces annually. Stillman and Kelly
will share $250,000 and each will receive a gold medallion. To
date, GMCRF has awarded nearly $14 million to 105 scientists
in an effort to focus worldwide scientific and public attention
on cancer research.
The other 2004 GMCRF Award winners are: Robert Langer, professor
of Chemical and Biomedical Engineering at the Massachusetts Institute
of Technology (MIT) in Cambridge, Mass. (Charles F. Kettering
Prize); and Dr. Charles J. Sherr, Herrick Foundation chair of
Genetics and Tumor Cell Biology at St. Jude Children’s
Research Hospital in Memphis, Tenn. (Charles S. Mott Prize).
The Kettering Prize recognizes the most outstanding recent contribution
to the diagnosis or treatment of cancer. The Mott Prize is given
for the most outstanding recent contribution related to the cause
or prevention of cancer.
"Through these awards, GM supports
some of the world’s most gifted scientists, who have made
highly important discoveries leading to the diagnosis, prevention
and treatment of cancer,” Wells said. “Research is
the basis for all cancer breakthroughs, and we must do everything
we can to support and nurture that spirit of discovery.”
The GMCRF Annual Scientific Conference, held at the National
Institutes of Health on June 8 and 9, focused on “Genome
Integrity and Cancer” and included a lecture by Stillman
describing his research. GM presented the prizes to the laureates
during an awards ceremony at the U.S. Department of State on
the evening of June 9.
About Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory is a private, non-profit education
and research institution. Under the leadership of Dr. Bruce Stillman,
more than 330 scientists at the Laboratory conduct groundbreaking
research in cancer, neurobiology, plant genetics and bioinformatics.
Cold Spring Harbor Laboratory also has innovative education programs
for active scientists, graduate students and for high school
education in biology. For more information, visit www.cshl.edu.
About General Motors
General Motors Corp. (NYSE: GM), the world's largest vehicle
manufacturer, employs about 325,000 people globally. Founded
in 1908, GM has been the global automotive sales leader since
1931. GM today has manufacturing operations in 32 countries and
its vehicles are sold in 192 countries. In 2003, GM sold nearly
8.6 million cars and trucks, about 15 percent of the global vehicle
market. GM's global headquarters are at the GM Renaissance Center
in Detroit. More information on GM and its products can be found
on the company's corporate website at www.gm.com.
Contact:
Leah Haran
248.458.8383
leah.haran@hassmsl.com
Return to
Press Release Index
|